نتایج جستجو برای: cachexia

تعداد نتایج: 3974  

2017
Vickie E Baracos

s of the 3rd International Conference on Cancer Cachexia, September 23–25, 2016 in Washington, DC, USA The 3rd International Conference on Cancer Cachexia titled, “Advancing Molecular Mechanisms and Therapies” took place on September 23–25, 2016, in Washington, DC. This meeting followed the 1st conference in 2012 in Boston, USA, and the 2nd in 2014 in Montreal, Canada. The goal for the 3rd meet...

Journal: :Journal of applied physiology 2014
Melissa J Puppa E Angela Murphy Raja Fayad Gregory A Hand James A Carson

While exercise benefits have been well documented in patients with chronic diseases, the mechanistic understanding of cachectic muscle's response to contraction is essentially unknown. We previously demonstrated that treadmill exercise training attenuates the initiation of cancer cachexia and the development of metabolic syndrome symptoms (Puppa MJ, White JP, Velazquez KT, Baltgalvis KA, Sato S...

2016
Masatoshi Shiono Kan Huang Robert J. Downey Nikita Consul Nicolas Villanueva Kristen Beck Kathleen Fenn Donald Dietz Takuhiro Yamaguchi Shunsuke Kato Chaitanya Divgi Kevin Kalinsky Ying Wei Yuan Zhang Alain C. Borczuk Akira Inoue Balazs Halmos Swarnali Acharyya

Weight loss and hematogenous metastases are poor prognosis factors in lung cancer patients that can but do not necessarily co-occur. We retrospectively investigated the clinical association between cachexia, tumor characteristics (such as metastatic burden and mutational status), and treatment in lung cancer patients. The medical records of 394 lung cancer patients from two institutions (Columb...

2017
Katherine A Michaelis Xinxia Zhu Kevin G Burfeind Stephanie M Krasnow Peter R Levasseur Terry K Morgan Daniel L Marks

BACKGROUND Cachexia is a complex metabolic and behavioural syndrome lacking effective therapies. Pancreatic ductal adenocarcinoma (PDAC) is one of the most important conditions associated with cachexia, with >80% of PDAC patients suffering from the condition. To establish the cardinal features of a murine model of PDAC-associated cachexia, we characterized the effects of implanting a pancreatic...

2017
Junichi Ishida Masakazu Saitoh Jochen Springer

Cancer cachexia is a complex syndrome, characterized by weight loss consisting of skeletal muscle loss and adipose tissue wasting, leading to poor outcomes. There are no established treatments for cancer cachexia, although recent pre-clinical and clinical studies have shown the promising effects of several agents including ghrelin, myostatin/activin pathway antagonists, androgenic steroids and ...

2011
James P. White Kristen A. Baltgalvis Melissa J. Puppa Shuichi Sato John W. Baynes James A. Carson

White JP, Baltgalvis KA, Puppa MJ, Sato S, Baynes JW, Carson JA. Muscle oxidative capacity during IL-6-dependent cancer cachexia. Am J Physiol Regul Integr Comp Physiol 300: R201–R211, 2011. First published December 9, 2010; doi:10.1152/ajpregu.00300.2010.—Many diseases are associated with catabolic conditions that induce skeletal muscle wasting. These various catabolic states may have similar ...

ژورنال: بیماری های پستان 2020

Introduction: Cachexia is a cancer complication that is associated with increased weight loss. Apoptosis has been known as one of the tissue-wasting pathways that cause weight loss and multiple organ failure in cancer-related cachexia. Various factors, including exercise training, can be effective in the reduction of cancer cachexia. In the present study, the effect of four weeks of high-intens...

2011
Renata Silvério Alessandro Laviano Filippo Rossi Fanelli Marília Seelaender

Cancer cachexia is a multifaceted syndrome characterized, among many symptoms, by extensive muscle wasting. Chronic systemic inflammation, partly triggered and sustained by cytokines, as well as increased oxidative stress contributes to the pathogenesis of this complex metabolic disorder. l-carnitine plays a central role in the metabolism of fatty acids and shows important antioxidant and anti-...

2015
Stephan von Haehling

Sarcopenia (muscle wasting) and cachexia share some pathophysiological aspects. Sarcopenia affects approximately 20 %, cachexia <10 % of ambulatory patients with heart failure (HF). Whilst sarcopenia means loss of skeletal muscle mass and strength that predominantly affects postural rather than non-postural muscles, cachexia means loss of muscle and fat tissue that leads to weight loss. The was...

2017
Brandon N VanderVeen Dennis K Fix James A Carson

Chronic inflammation is a hallmark of cancer cachexia in both patients and preclinical models. Cachexia is prevalent in roughly 80% of cancer patients and accounts for up to 20% of all cancer-related deaths. Proinflammatory cytokines IL-6, TNF-α, and TGF-β have been widely examined for their regulation of cancer cachexia. An established characteristic of cachectic skeletal muscle is a disrupted...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید